drugset / Trial / NCT03008915
Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
Phase 2
Completed
15 enrolled
Columbia University
Alpha-1 Foundation · collabStony Wold-Herbert Fund, Inc. · collab
RandomizedCrossoverQuadruple-blindOther
Summary
The aim of this study is to test whether aspirin improves endothelial function in alpha-1 antitrypsin deficiency-associated lung disease, measured by pulmonary microvascular blood flow on magnetic resonance imaging (MRI) and with apoptotic endothelial microparticles.
Timeline
- Start
- 2017-01
- Primary completion
- 2018-07
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 81 mg | — |